{"prompt": "['InterStim Amplitude Clinical Investigation Plan', 'MDT17030', 'Version 2.0', 'Page 38 of 61', 'Medtronic', '(ISO 14155:2011', 'Use Error: Act or omission of an act that results in a different medical', '3.43)', 'device response than intended by the manufacturer or expected by the', 'user', 'NOTE 2 Use error includes slips, lapses, mistakes.', 'NOTE 3 An unexpected physiological response of the subject does not in itself', 'constitute a use error.', 'SERIOUSNESS', 'Serious Adverse', 'Adverse event that', 'Event (SAE)*', 'a) led to a death,', '(ISO 14155:2011', 'b) led to a serious deterioration in the health of the subject, that either', '3.37)', 'resulted in:', '1. a life-threatening illness or injury, or', '2. a permanent impairment of a body structure or a body function, or', '3. in-patient or prolonged hospitalization, or', '4. medical or surgical intervention to prevent life-threatening illness or', 'injury or permanent impairment to a body structure or a body', 'function.', 'c) led to foetal distress, foetal death or a congenital abnormality or birth', 'defect.', 'NOTE Planned hospitalization for pre-existing condition, or a procedure required', 'by the CIP, without serious deterioration in health, is not considered a serious', 'adverse event.', 'Serious Adverse', 'Adverse device effect that resulted in any of the consequences characteristic of a', 'Device Effect', 'serious adverse event', '(SADE)*', '(ISO 14155:2011', '3.36)', 'Unexpected', 'Serious adverse device effect which by its nature, incidence, severity or outcome', 'Serious Adverse', 'has not been identified in the current version of the risk analysis report', 'Device Effect', '(USADE)*', 'Medtronic Confidential', '056-F275, v3.0 Clinical Investigation Plan Template']['InterStim Amplitude Clinical Investigation Plan', 'MDT17030', 'Version 2.0', 'Page 39 of 61', 'Medtronic', '(ISO 14155:2011', 'NOTE Anticipated serious adverse device effect (ASADE) is an effect by which its', '3.42)', 'nature, incidence, severity or outcome has been identified in the risk analysis', 'report.', 'RELATEDNESS', 'Relationship of', 'The relationship of the adverse event to the study treatment (device, therapy,', 'Adverse Events', 'procedure) will be described using the following terms:', 'Not related', 'Unlikely', 'Possible', 'Probable', 'Causal relationship', '*Reportable event categories that will be collected during this study', '11.2. Report of Adverse Events', 'Any adverse event meeting the definition of serious, device-related, procedure-related and/or therapy-', 'related as well as all device deficiencies as defined above will be considered reportable for this study.', 'The following are not adverse events:', 'Transient effects that occur during the implant procedure or programming and', 'resolve without reprogramming.', 'Any normal expected postoperative complaints or symptoms unless the event', 'involves a clinically significant change in severity or duration of symptoms or requires', 'clinical intervention that is different from ordinary postoperative care. Expected', 'postoperative outcomes include headache, incisional pain, nausea, vomiting, low', 'grade fever, oozing at dressing, dizziness, irritability, sleepiness, nervousness,', 'insomnia, constipation, urinary retention, confusion and similar events.', 'Worsening of OAB symptoms will be collected as part of the efficacy measures and', 'are not considered a reportable adverse event.', 'For reporting of all serious adverse events and/or serious adverse device effects, the following', 'emergency Sponsor contact may be used:', 'Phone: 1+763.526.8102', 'Email: rs.pelvichealthresearchnetwork@medtronic.com', 'Address: 7000 Central Avenue NE, RCE 375 I Minneapolis, MN, 55432 I', 'USA', 'Medtronic Confidential', '056-F275, v3.0 Clinical Investigation Plan Template']['InterStim Amplitude Clinical Investigation Plan', 'MDT17030', 'Version 2.0', 'Page 40 of 61', 'Medtronic', 'All reportable adverse events will be classified using the following responsibility matrix:', 'Table 11-2 Event Classification Responsibilities', 'What is Classified', 'Who Classifies', 'Classification Parameters', 'Procedure related', 'Relatedness', 'Investigator', 'Device related', 'Therapy related', 'USADE potential', 'Medtronic', 'USADE', 'Seriousness', 'Investigator', 'SAE/SADE', 'Based on presenting signs and symptoms and', 'Investigator', 'other supporting data', 'Diagnosis', 'MedDRA term assigned based on the data', 'Medtronic', 'provided by investigator', \"All reportable adverse events must be recorded in the subject's medical record and on an Adverse Event\", 'and/or Device Deficiency eCRF and promptly reported to Medtronic based on Table 11-2. IRB/EC', 'reporting must be completed in accordance with the policies of the governing IRB/EC. Governing', 'regulatory authority reporting should be completed in accordance with applicable local regulations.', 'Reports of adverse events and device deficiencies will include the following information, at a minimum:', 'Date of event', 'Diagnosis or description of the event', 'Assessment of the seriousness and relationship to the product(s) under study', 'Treatment', 'Outcome and date of resolution', 'It is the responsibility of the Investigator to identify the occurrence of reportable adverse events and', 'device deficiencies and to ensure the required information is accurately documented on the eCRF.', 'The clinical course of each adverse event must be followed until resolution or subject discontinuation', 'from the study, whichever comes first. \"Ongoing\" adverse events and device deficiencies must be', 'assessed at each protocol required visit, and new or updated information must be documented on the', 'Adverse Event and/or Device Deficiency eCRF and promptly reported to Medtronic and if applicable to', 'the IRB/EC. Commercial medical device reporting processes will be followed for complaint handling.', 'If necessary, the Investigator may report to the sponsor initially by telephone or email and follow-up', 'with completed eCRFs and, if possible, copies of source documentation regarding the event (e.g.,', 'physician/nurse notes or summaries).', 'Medtronic study personnel will promptly review all reported adverse events and device deficiencies and', 'Medtronic Confidential', '056-F275, v3.0 Clinical Investigation Plan Template']\n\n###\n\n", "completion": "END"}